ENTITY
Astellas Pharma

Astellas Pharma (4503 JP)

121
Analysis
Health CareJapan
Astellas Pharma Inc. is a pharmaceutical company committed to the therapeutic fields of Urology, Immunology including Transplantation and Infectious Diseases, Oncology, Neuroscience and DM Complications and Metabolic Diseases. With over 17,000 global employees, Astellas researches, develops, manufactures, and promotes its prescription drugs through subsidiaries in the US, Europe, and Asia
more
Refresh
bearishFast Retailing
23 Jul 2018 07:38

JAPAN PASSIVE:  The Nikkei 225 Baskets if BOJ Changes

Last week in JAPAN PASSIVE:  BOJ Heading For Trouble with Nikkei 225 I discussed the BOJ's past and current ETF purchasing selection, ownership,...

Logo
556 Views
Share
bearishFast Retailing
19 Jul 2018 02:00

JAPAN PASSIVE:  BOJ Heading For Trouble with Nikkei 225

The last couple of weeks have seen stories carried in the media about the impact of the BOJ in its equity index ETF buying program. Some of these...

Logo
1.6k Views
Share
bullishOtsuka Holdings
29 Jun 2018 21:11

Opportunities in The (Overpriced) Japan Pharma Sector

As a defensive sector, Japan’s pharmaceutical sector has had an up-and-down time of it during the Abe era. In the early days of Abenomics, the...

bullishMSCI ACWI Index
14 Jun 2018 20:25

Global Equity Markets Overview

Over the past several weeks we have outlined the case for our increasingly bullish outlook, noting that market internals remain favorable and...

Logo
118 Views
Share
bullishMSCI ACWI Index
24 May 2018 20:43

Global Strategy: Opportunities in Health Care & Materials Stocks

Price and relative strength trends continue to improve for our international equal-weight Health Care Sector.We recommend adding exposure, and...

Logo
238 Views
Share
x